Pliant Therapeutics, Inc.

PLRX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001746473

SEC filings (opens in a new tab)

No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Pliant Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of PLRX: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	151	1	161	+11
Shares	63.5M	288.7K	64.8M	+1.55M (+2.5%)
Value	$710.6M	$3.24M	$852.6M	+$145.2M (+20.5%)

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Pliant Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to PLRX in Q4 2024
Institution	Shares	Value	% of portfolio
Silverarc Capital Management, LLC	1,315,601	$17.3M	3.87%
Frazier Life Sciences Management, L.P.	1,120,803	$14.8M	0.61%
Logos Global Management LP	750,000	$9.88M	1.16%
Adage Capital Partners GP, L.L.C.	649,660	$8.56M	0.01%
Caption Management, LLC	142,404	$1.88M	0.08%
Atom Investors LP	130,448	$1.72M	0.21%
Marshall Wace, LLP	53,880	$709.6K	0.00%
Jump Financial, LLC	19,402	$255.5K	0.01%
Police & Firemen's Retirement System of New Jersey	12,610	$166.1K	0.00%
Advisor Group Holdings, Inc.	11,755	$154.8K	0.00%
Corton Capital Inc.	10,497	$138.2K	0.08%
KLP Kapitalforvaltning AS	8,200	$108.0K	0.00%
BNP Paribas Arbitrage, SA	7,512	$98.9K	0.00%
R Squared Ltd	2,490	$32.8K	0.03%
GF Fund Management Co. Ltd.	1,278	$16.8K	0.00%
MAI Capital Management	400	$5.27K	0.00%
SBI Securities Co., Ltd.	110	$1.45K	0.00%
Creative Planning	109	$1.44K	0.00%
Amundi	52	$656	0.00%
SRS Capital Advisors, Inc.	46	$606	0.00%
Jones Financial Companies LLLP	24	$316	0.00%
Cornerstone Planning Group LLC	24	$264	0.00%
IFP Advisors, Inc	0	$145	0.00%
WealthTrak Capital Management LLC	10	$132	0.00%

Sold out (13)

Institutions that held Pliant Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of PLRX in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Millennium Management LLC	244,640	$2.74M
Capital International Investors	224,997	$2.52M
Natixis	55,000	$616.5K
HarbourVest Partners LLC	49,434	$554.2K
Connor, Clark & Lunn Investment Management Ltd.	34,611	$388.0K
Y-Intercept (Hong Kong) Ltd	30,471	$341.6K
Tudor Investment Corp Et Al	22,628	$253.7K
Graham Capital Management, L.P.	13,986	$156.8K
Engineers Gate Manager LP	12,229	$137.1K
Brevan Howard Capital Management LP	10,260	$115.0K
Profund Advisors LLC	10,077	$113.0K
Northwestern Mutual Wealth Management Co	30	$336
National Bank of Canada	8	$90

Not filed for Q4 2024 yet (1)

Institutions that held Pliant Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PLRX in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Mass General Brigham, Inc	288,690	$3.24M